An Australian court has ordered a British consumer goods company to pay 6 million Australian dollars ($4.4 million) in penalties for misleading consumers about the effectiveness of a popular painkiller, according to AP. The full-bench of the Federal Court on Friday upheld an appeal by the Australian Competition and Consumer Commission, the watchdog which launched the court action, against an AU$1.7 million fine imposed on Reckitt Benckiser in April. The Federal Court ruled a year ago that Reckitt Benckiser deceived Australians by selling Nurofen painkillers that were marketed to relieve specific ailments, such as back pain and period pain, when all of the products contained an identical amount of the same active ingredient, ibuprofen lysine. The court ordered the company to remove the products from Australian stores.
